Source: PR Newswire

Press Release: Sojournix : Sojournix to Present at Stifel 2019 Healthcare Conference

WALTHAM, Mass., Nov. 5, 2019 /PRNewswire/ -- Sojournix, a clinical stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders, announces that Daniel Grau, Chief Executive Officer...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

Co-Founder & CEO

Daniel Grau

CEO Approval Rating

84/100

Read more